Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...

Through this agreement, Xcellbio scientists will work with the Royal Perth Hospital team to develop an automated TIL manufacturing process based on AVATAR platform that achieves key goals for cell ...

Adia Nutrition (OTC Pink: ADIA), a trailblazer in advanced healthcare solutions, is excited to announce that its subsidiary, ...

Unifor Local 922 members at Nutrien have voted in favour of a new collective agreement that delivers wage increases and benefit improvements. "Potash miners help extract a key strategic resource for ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a ...

ORIC-944 is a potent, highly selective, orally bioavailable, allosteric inhibitor of PRC2 that demonstrates best-in-class drug properties, including potency, solubility, and pharmacokinetics, with ...

Long before laboratories and clinical trials, indigenous healers recognized the extraordinary properties of miracle leaf.

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Cannabis is packed with powerful compounds beyond THC and CBD—discover 10 key cannabinoids and how they impact your ...

Genuine findings of the Mitolyn review indicate that Mitolyn is a legitimate weight loss supplement that contains ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), resu ...